Do PPIs diminish Barrett's esophagus length or cancer risk?

Affiliations

Comment

Yvonne Romero. Nat Clin Pract Gastroenterol Hepatol. 2006 Dec.

. 2006 Dec;3(12):658-9.

doi: 10.1038/ncpgasthep0657.

¹ Division of Gastroenterology & Hepatology, Mayo Clinic, 200 First Street, Rochester, MN 55901, USA. romero.yvonne@mayo.edu

No abstract available

Comment on

Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence.
Cooper BT, Chapman W, Neumann CS, Gearty JC. Cooper BT, et al. Aliment Pharmacol Ther. 2006 Mar 15;23(6):727-33. doi: 10.1111/j.1365-2036.2006.02825.x. Aliment Pharmacol Ther. 2006. PMID: 16556174